Did One Stop Systems beat or miss consensus estimates last quarter?

What is the revenue and EPS growth rate for One Stop Systems year over year?

What is One Stop Systems's gross profit margin?

What were the key takeaways from One Stop Systems’s earnings call?

What does One Stop Systems do and what are its main business segments?

What factors drove the changes in One Stop Systems's revenue and profit?

What guidance did One Stop Systems's management provide for the next earnings period?

What is the market's earnings forecast for One Stop Systems next quarter?

- **Record Q4 Performance**: 70% YoY revenue growth to $12M, 58.5% gross margin, $2M net income. Full-year revenue exceeded $30M.
- **Strategic Shift**: Sold Bressner for $22.4M, refocusing on rugged AI compute. 2026 guidance: 20-25% revenue growth, 40% gross margin, positive EBITDA.
- **Defense Wins**: $10.5M P-8 awards, $1.2M Safran follow-on order, $2M medical imaging production. 
- **Commercial Expansion**: Robotics, aerospace, and healthcare engagements displacing incumbents.
- **Risks**: Supply chain delays (memory components), potential Q1 revenue seasonality.

**【CEO Summary Section】**
- **Strategic Shift and Financial Milestones**: Sold Bressner for $22.4M, transitioning to a pure-play rugged AI compute provider. Q4 2025 revenue grew 70.2% YoY to $12M, with record gross margin of 58.5% and $2M net income. Full-year revenue exceeded guidance at $30M+.
- **Defense and Commercial Growth**: 
  - **P-8 Program**: Secured $10.5M in new awards, part of $65M+ contracted revenue. 
  - **Safran Partnership**: $1.2M follow-on order, with potential $7M+ over 5 years. 
  - **Medical Imaging**: $2M follow-on order, projecting $25M+ over 5 years. 
  - **Robotics and Aerospace**: New engagements displacing incumbents, driven by AI/ML adoption.
- **2026 Outlook**: 20-25% revenue growth, 40% gross margin, positive EBITDA. Focus on customer-funded R&D and supply chain management amid memory component delays.

**【CFO Financial Commentary】**
- **Q4 2025 Results**: 
  - Revenue: $12M (70.2% YoY growth). 
  - Gross Margin: 58.5% (vs. 26.8% prior year). 
  - Net Income: $2M (vs. -$3.4M YoY). 
  - Cash: $33.4M post-Bressner sale, no debt.
- **2026 Guidance**: 
  - Revenue: $48-53M (20-25% growth). 
  - Gross Margin: ~40%. 
  - EBITDA: Positive, with 60% of revenue in H2.
- **Expense Management**: R&D at 10-12% of revenue, disciplined cost control.

**【Q&A Key Highlights】**
- **Pipeline Visibility**: 2026 guidance supported by $10.5M P-8 awards and medical device production ramp. Defense budget clarity improves timing, but supply chain delays may impact quarters.
- **M&A Strategy**: Actively evaluating adjacencies in hardware and software, prioritizing strategic fit over speed. No timeline for accretion, but funnel is active.
- **Sales Expansion**: Hiring and distributor engagement to support 20-25% growth, with 40% of 2026 revenue in H1.
- **Commercial vs. Defense Mix**: ~50-50 split, flexible to demand. Robotics and healthcare emerging as high-growth commercial segments.
- **Enhanced Vision System**: Army testing late 2026, potential for multi-year programs if adopted. Addressable market in tens to hundreds of vehicles, depending on program of record scope.

One Stop Systems, Inc.(OSS)-20260318-2025 Q4 Earnings call transcript

- **Revenue Growth Acceleration**: Q3 2025 revenue up 36.9% YoY, with full year guidance raised to $63M-$65M.
- **Strategic Wins**: P-8 Poseidon sole-source extension, medical imaging partnership ($25M+), and Canadian aerospace order ($6M+ over 3 years).
- **Financial Strength**: Positive EBITDA ($1.2M), $12.5M funding boost, and 2026 growth outlook of 20%-30% for OSS segment.
- **Commercial Expansion**: Gen 6 systems launch, data center partnerships, and Bressner segment on track for 2025 profitability.
- **Risk Management**: Government shutdown delays bookings timing, but demand intact.


**【CEO Summary Section】**
- **Revenue Growth and Strategic Momentum**: Q3 2025 revenue of $18.8M (+36.9% YoY) driven by strong demand in defense and commercial markets. Full year guidance raised to $63M-$65M, up from $59M-$61M.
- **Key Contracts and Expansion**: 
  - P-8 Poseidon program with $5M+ lifetime revenue and 5-year sole-source extension.
  - Medical imaging partnership with $25M+ 5-year program value.
  - $1.5M Canadian aerospace order, expected to contribute $6M over 3 years.
- **Product Development and Commercialization**: 
  - Ponto high-density GPU system under evaluation with commercial customers.
  - Launch of 2 new Gen 6 systems in November targeting AI/ML and data-centric workloads.
  - $12.5M registered direct offering to strengthen balance sheet and support growth.
- **Pipeline and Market Trends**: 
  - Trailing 12-month OSS segment book-to-bill ratio of 1.4.
  - Defense bookings impacted by government shutdown, but demand remains strong.
  - Bressner segment on track for higher 2025 sales and profitability.

**【CFO Financial Commentary】**
- **Financial Highlights**: 
  - Consolidated gross margin 35.7% (OSS segment 45.6%, Bressner 26%).
  - GAAP net income $0.3M vs. $6.8M loss YoY; Non-GAAP net income $0.7M vs. $6.4M loss YoY.
  - Positive EBITDA ($1.2M) and cash flow improvements.
- **Balance Sheet Strength**: 
  - $6.5M cash post-Q3, with $12.5M raised post-quarter for working capital and M&A.
  - 2025 guidance: OSS segment revenue $30M-$32M (+22%-30% YoY).
- **Cost Management**: 
  - Operating expenses +22% YoY due to R&D investments.
  - Targeting OSS segment margins 35%-45%.

**【Q&A Highlights】**
- **Seasonality and Government Shutdown**: 
  - Q4 bookings timing delays due to government shutdown, but no demand loss.
  - 2026 growth expected at 20%-30% YoY for OSS segment.
- **Commercial Opportunities**: 
  - Data center expansion with Ponto and Gen 6 systems.
  - Medical imaging and aerospace partnerships driving diversification.
- **Bressner Performance**: 
  - Q3 revenue +$2.3M (FX +$0.6M, organic +$1.7M).
  - Q4 expected flat to Q3, with 2026 growth 5% YoY.
- **Cash Deployment**: 
  - Working capital support and M&A strategy for 2026.


One Stop Systems, Inc. (OSS) Q3 2025 Earnings Call Transcript

- **Revenue Growth**: 6.9% YoY increase to $14.1 million, with OSS segment targeting $30 million for 2025 (20% YoY growth).
- **New Product Launch**: Ponto platform for composable infrastructure expected to contribute $25 million over 5 years.
- **Bookings Strength**: $25.4 million in first-half bookings, book-to-bill ratio of 2.3.
- **Financial Targets**: EBITDA breakeven for the year, gross margin expansion to 40% for the OSS segment.
- **Risks**: Supply chain lead times and government funding timing impacting second-half execution.

**【CEO Summary Section】**
- **Q2 2025 Highlights**: Revenue growth driven by defense and commercial contracts, including a $6.5 million defense contract and a $2 million medical imaging order. Bookings reached $25.4 million (book-to-bill ratio 2.3), with a focus on platform opportunities like the P-8A Poseidon program.
- **Strategic Initiatives**: Launch of Ponto, a PCIe Gen 5 GPU expansion platform targeting composable infrastructure. Increased R&D investments to capitalize on AI, machine learning, and edge computing trends.
- **Guidance**: Full-year OSS segment revenue expected to reach $30 million (20% YoY growth), with EBITDA breakeven at a consolidated level. Second-half revenue projected at $19 million for the OSS segment.

**【CFO Financial Commentary】**
- **Q2 2025 Financials**: Consolidated revenue of $14.1 million (6.9% YoY growth), gross margin expanded to 31.3% (up 610 basis points YoY). OSS segment gross margin improved to 41.3% due to product mix and operational efficiency.
- **Cost Management**: Operating expenses increased 11.6% to $6.2 million, driven by R&D investments. GAAP net loss of $2 million, with adjusted EBITDA loss of $1 million.
- **Balance Sheet**: $9.5 million in cash, no borrowings on revolving credit. Full-year guidance for consolidated revenue of $59-$61 million and EBITDA breakeven.

**【Q&A Highlights】**
- **Bressner Segment**: Expected to grow in line with historical rates (7-9%), with cautious outlook due to supply chain risks. European market recovery and defense spending in Germany may drive future growth.
- **Data Center Opportunities**: Ponto product launch targeting 2026 revenue contribution. Engaging with AI partners for integrated solutions and exploring AI accelerator architectures.
- **Supply Chain Risks**: Longer lead times for components, with focus on disciplined execution for second-half production ramp.
- **Government Funding**: Uncertainty in timing of program releases, but strong pipeline alignment with defense and commercial AI trends.

One Stop Systems (OSS)-7 Aug 25-2025 Q2 Earnings call transcript

- **Q1 2025 Financial Resilience**: $12.3M revenue with 32.6% gross margin, up 320bps YoY, driven by 45.5% OSS segment margin.
- **$6.5M Defense Win**: Full 2025 delivery of record contract, part of $30M+ H2 revenue pipeline.
- **Strategic Momentum**: 2.0 book-to-bill ratio, $200M+ Army program in evaluation, and 6U GPU product line targeting data centers.
- **2025 Guidance Confidence**: On track for $59-61M revenue and EBITDA breakeven, with H2 growth from delayed H1 orders and new programs.
- **Competitive Edge**: Tariff-advantaged U.S. manufacturing and 350% faster compute solutions driving defense and medical wins.

**【CEO Summary Section】**
- **Revenue Stability & Margin Improvement**: Q1 2025 consolidated revenue of $12.3 million (-3.1% YoY), with OSS segment gross margin at 45.5% (vs. 34.2% YoY). A $6.5 million defense contract award highlights strong demand in edge compute solutions.
- **Strategic Growth Drivers**: 
  1. **Early-Stage Collaborations**: Customer-funded development programs (e.g., P-8 Poseidon radar systems) targeting long-term production orders.
  2. **Land-and-Expand Strategy**: Ruggedized compute solutions 350% faster than competitors, winning 3 defense contracts in 8 months.
  3. **Integrated Solutions**: Combining compute/storage to expand beyond prime contracts, e.g., $25M+ medical imaging partnership.
- **Pipeline Momentum**: Q1 2025 OSS segment book-to-bill ratio of 2.0, trailing 12-month ratio of 1.33. Key wins include $1.4M P-8 radar systems and $500K medical imaging contract with $25M+ follow-on potential.
- **2025 Guidance**: Target $59-61M revenue, EBITDA breakeven, with H2 growth driven by delayed H1 orders and new program transitions.

**【CFO Financial Commentary】**
- **Q1 2025 Financials**: 
  - GAAP net loss of $2.0M (-54% YoY), non-GAAP loss of $1.4M (-47% YoY). 
  - Adjusted EBITDA loss of $1.1M (vs. $0.5M YoY). 
  - Operating expenses up 19.2% to $5.9M due to sales and R&D headcount additions.
- **Segment Performance**: 
  - OSS segment gross margin 45.5% (vs. 34.2% YoY), driven by higher-margin product mix and $212K inventory reserve reversal. 
  - Bressner segment margin 23.1% (vs. 25.7% YoY) due to product mix.
- **Liquidity**: $9.1M cash, no debt on revolving line, $1.1M term loan balance. Q1 cash usage of $1.1M vs. $2.0M YoY.

**【Q&A Key Highlights】**
- **Order Visibility**: ~70% of 2025 $30M OSS revenue target from signed contracts, with H2 deliveries for Q1 bookings.
- **Defense Opportunity**: $200M+ Army situational awareness program in evaluation phase, with potential multi-year awards.
- **Data Center Growth**: 6U GPU expansion chassis expected to generate H2 2025 revenue, targeting mobile and extended data centers.
- **Tariff Advantage**: U.S.-based manufacturing displacing Asian competitors, with Bressner segment capturing EU supply chain shifts.
- **Government Spending**: 2026 DoD budget acceleration may unlock delayed 2025 programs, e.g., $1.6M Virginia-class submarine upgrades.
- **Gross Margin Sustainability**: OSS segment targeting mid-30%+ margins, excluding customer-funded R&D (15-20% margin).

One Stop Systems (OSS)-7 May 25-2025 Q1 Earnings call transcript

- **Revenue Recovery**: 15.1% YoY growth in Q4 2024, first year of sequential growth across all quarters.
- **Margin Outlook**: Targeting 30%+ gross margin in 2025 after 2024 volatility driven by lower-margin product mix.
- **2025 Growth**: $59-61M revenue target with EBITDA breakeven, fueled by $200M+ composable infrastructure and U.S. Army combat vehicle programs.
- **Pipeline Strength**: $1B+ pipeline with $200M+ addressable in 2025, balanced between defense and commercial markets.
- **Cash Position**: $10M cash, no debt, strong liquidity for growth initiatives.

**【CEO Opening Remarks】**
- **Revenue Growth**: Consolidated revenue increased 15.1% YoY to $15.1M in Q4 2024, driven by double-digit growth in both OSS and Bressner segments. 2024 marked the first year of sequential growth for every quarter.
- **Segment Performance**: OSS segment revenue grew 20% YoY in 2024, supported by defense (U.S. Army, Navy, intelligence agency) and commercial (data center, healthcare, aerospace) wins. Customer-funded development revenue surged 118% to $3.7M.
- **2025 Outlook**: Projected consolidated revenue of $59-61M (20%+ OSS segment growth) with EBITDA breakeven. Key opportunities include:
  - $200M+ composable infrastructure pipeline for data centers
  - $200M+ U.S. Army combat vehicle visualization program
  - New healthcare customer with 5-year production orders
- **Pipeline Strength**: $1B+ pipeline with 2025 addressable portion at $200M+. Book-to-bill ratio of 1.14 in 2024, targeting 1.2 for 2025.

**【CFO Financial Highlights】**
- **Q4 2024 Results**: 
  - GAAP net loss: $3.1M (-$0.15/share) vs. $0.01M loss prior year
  - Non-GAAP net loss: $2.6M (-$0.12/share) vs. $0.01M income prior year
  - Adjusted EBITDA loss: $2.3M (includes $1.2M one-time contract loss)
- **Gross Margin**: 15.7% (15.1M revenue), constrained by lower-margin mix. Excluding one-time charges, gross margin was 23.8%. Targeting 30%+ in 2025.
- **Cash Position**: $10M cash, no debt on $2M revolver, $1M term loan balance.
- **Cost Control**: Operating expenses up 15.1% YoY to $5.5M, driven by planned investments in sales and marketing.

**【Q&A Key Takeaways】**
1. **Gross Margin Volatility**: 2024 Q4 gross margin pressured by lower-margin products (e.g., customer-funded NRE). Full year 2024 gross margin (ex one-time charges) was stable at 36.4%.
2. **Order Delays**: Defense budget uncertainty causing Q1/Q2 delays, but pipeline stability maintained. 2025 growth expected to accelerate in H2.
3. **Market Mix**: Balanced growth between defense (U.S. Army, Navy) and commercial (data center, healthcare) markets. Healthcare imaging orders growing faster than anticipated.
4. **R&D Pipeline**: Multiple customer-funded development programs in pipeline, similar to successful P-8 program. These can lead to multiyear production contracts.

Actual										-0.04	0.01	0.07	0.04	0.03	0.04	0.08	0	0.05	0.04	0.03	-0.14	0	0	-0.03	0.01	-0.04	-0.09	-0.3	-0.12	-0.07	-0.07	0.03	0.1
Forecast										-0.06	-0.0633	0.0167	0.0533	0.0067	0.015	0.062	0.06	0.02	0.034	0.04	0.0425	0.035	0.0325	-0.054	-0.044	-0.05	-0.05	-0.07	-0.0067	-0.0567	-0.07	0.0133	0.03
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+33.33%	+115.80%	+319.16%	-24.95%	+347.76%	+166.67%	+29.03%	-100.00%	+150.00%	+17.65%	-25.00%	-429.41%	-100.00%	-100.00%	+44.44%	+122.73%	+20.00%	-80.00%	-328.57%	-1691.04%	-23.46%	0.00%	+125.56%	+233.33%

OSS

OSS fundamentals

OSS Q4 2025 Earnings

Earnings Call

You can ask Aime

OSS

OSS fundamentals

OSS Q4 2025 Earnings

Earnings Call

OSS Earnings Call Summary for Q4/202510:00 AM on Mar 18, 2026

OSS Earnings Call Summary for Q3/202510:00 AM on Nov 5, 2025

OSS Earnings Call Summary for Q2/202510:00 AM on Aug 7, 2025

OSS Earnings Call Summary for Q1/202510:00 AM on May 7, 2025

OSS Earnings Call Summary for Q4/202410:00 AM on Mar 19, 2025

You can ask Aime